265 related articles for article (PubMed ID: 17397297)
61. Biomarkers for cystic fibrosis lung disease: application of SELDI-TOF mass spectrometry to BAL fluid.
MacGregor G; Gray RD; Hilliard TN; Imrie M; Boyd AC; Alton EW; Bush A; Davies JC; Innes JA; Porteous DJ; Greening AP
J Cyst Fibros; 2008 Sep; 7(5):352-8. PubMed ID: 18243068
[TBL] [Abstract][Full Text] [Related]
62. [Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].
Lakomý R'; Greplová K; Pilný R; Budinská E; Valík D; Poprach A; Nemecek R; Vyzula R
Klin Onkol; 2009; 22(5):228-32. PubMed ID: 19886361
[TBL] [Abstract][Full Text] [Related]
63. Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples.
Zhong L; Taylor DL; Whittington RJ
Comp Immunol Microbiol Infect Dis; 2010 Jan; 33(1):47-63. PubMed ID: 18775566
[TBL] [Abstract][Full Text] [Related]
64. Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology.
Scarlett CJ; Smith RC; Saxby A; Nielsen A; Samra JS; Wilson SR; Baxter RC
Gastroenterology; 2006 May; 130(6):1670-8. PubMed ID: 16697731
[TBL] [Abstract][Full Text] [Related]
65. [The contribution for the diagnosis of the tumor-like polypoid lesions of the gallbladder by SELDI-TOF-MS].
Luan FM; Ge CL; Ma N; Li YZ; Hu CJ; Li N
Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(7):525-7. PubMed ID: 18785564
[TBL] [Abstract][Full Text] [Related]
66. Tree analysis of mass spectral urine profiles discriminates transitional cell carcinoma of the bladder from noncancer patient.
Zhang YF; Wu DL; Guan M; Liu WW; Wu Z; Chen YM; Zhang WZ; Lu Y
Clin Biochem; 2004 Sep; 37(9):772-9. PubMed ID: 15329315
[TBL] [Abstract][Full Text] [Related]
67. Proteomic profiling of mature CD10+ B-cell lymphomas.
Fan G; Molstad M; Braziel RM; Standley M; Huang J; Rodgers W; Nagalla S
Am J Clin Pathol; 2005 Dec; 124(6):920-9. PubMed ID: 16416742
[TBL] [Abstract][Full Text] [Related]
68. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
69. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
Harezlak J; Wang M; Christiani D; Lin X
Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
[TBL] [Abstract][Full Text] [Related]
70. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
[TBL] [Abstract][Full Text] [Related]
71. In-source decay causes artifacts in SELDI-TOF MS spectra.
Ekblad L; Baldetorp B; Fernö M; Olsson H; Bratt C
J Proteome Res; 2007 Apr; 6(4):1609-14. PubMed ID: 17373843
[TBL] [Abstract][Full Text] [Related]
72. [Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool].
Tomosugi N
Rinsho Byori; 2004 Dec; 52(12):973-9. PubMed ID: 15675343
[TBL] [Abstract][Full Text] [Related]
73. Peak quantification in surface-enhanced laser desorption/ionization by using mixture models.
Dijkstra M; Roelofsen H; Vonk RJ; Jansen RC
Proteomics; 2006 Oct; 6(19):5106-16. PubMed ID: 16955530
[TBL] [Abstract][Full Text] [Related]
74. [The application of surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in diagnosing dysplasia and chronic atrophic gastric-carditis in population with high risk of gastric-cardia adenocarcinoma].
Wang DC; Wang LD; Zheng S; Fan ZM; Li JL; Feng CW; Zhang YR; Liu B; Gao SS; He X
Zhonghua Nei Ke Za Zhi; 2005 Aug; 44(8):573-6. PubMed ID: 16194406
[TBL] [Abstract][Full Text] [Related]
75. [Construction of protein fingerprint signature in serum and its significance for early diagnosis with chronic allograft nephropathy].
Zhou ST; Yan JH; Yang C; Zeng N; Wu K; Chen ZH
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1966-9. PubMed ID: 17064591
[TBL] [Abstract][Full Text] [Related]
76. Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysis.
Florian-Kujawski M; Hussain W; Chyna B; Kahn S; Hoppensteadt D; Leya F; Fareed J
Int Angiol; 2004 Sep; 23(3):246-54. PubMed ID: 15765039
[TBL] [Abstract][Full Text] [Related]
77. Urinary proteomic profiles distinguish between active and inactive lupus nephritis.
Mosley K; Tam FW; Edwards RJ; Crozier J; Pusey CD; Lightstone L
Rheumatology (Oxford); 2006 Dec; 45(12):1497-504. PubMed ID: 17046860
[TBL] [Abstract][Full Text] [Related]
78. Influence of hormone replacement therapy on proteomic pattern in serum of postmenopausal women.
Gericke B; Koebnick C; Reimann M; Forterre S; Franz Zunft HJ; Schweigert FJ
Maturitas; 2005 Aug; 51(4):334-42. PubMed ID: 16039405
[TBL] [Abstract][Full Text] [Related]
79. Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay.
Song Z; Dong R; Fan Y; Zheng S
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):370-5. PubMed ID: 22569524
[TBL] [Abstract][Full Text] [Related]
80. Differential expression of proteins in kidney, eye, aorta, and serum of diabetic and non-diabetic rats.
Cho WC; Yip TT; Chung WS; Leung AW; Cheng CH; Yue KK
J Cell Biochem; 2006 Sep; 99(1):256-68. PubMed ID: 16598775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
